APA (7th ed.) Citation

F, R., JI, F., N, V., J, G., E, F., V, M., . . . LM, V. (2024). Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosis. Frontiers in immunology, 15, 1480676. https://doi.org/10.3389/fimmu.2024.1480676

Chicago Style (17th ed.) Citation

F, Rodríguez-Jorge, et al. "Biomarkers of Response to Ocrelizumab in Relapsing-remitting Multiple Sclerosis." Frontiers in Immunology 15 (2024): 1480676. https://doi.org/10.3389/fimmu.2024.1480676.

MLA (9th ed.) Citation

F, Rodríguez-Jorge, et al. "Biomarkers of Response to Ocrelizumab in Relapsing-remitting Multiple Sclerosis." Frontiers in Immunology, vol. 15, 2024, p. 1480676, https://doi.org/10.3389/fimmu.2024.1480676.